Aadi Bioscience, Inc.Aadi Bioscience, Inc.Aadi Bioscience, Inc.

Aadi Bioscience, Inc.

No trades
See on Supercharts
Market capitalization
‪46.65 M‬USD
−2.44USD
‪−65.77 M‬USD
‪24.35 M‬USD
‪17.44 M‬
Beta (1Y)
0.19

About Aadi Bioscience, Inc.

CEO
David Lennon
Headquarters
Los Angeles
Employees (FY)
89
Founded
2007
FIGI
BBG002WN7DT2
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AADI is 1.94 USD — it has increased by 2.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aadi Bioscience, Inc. stocks are traded under the ticker AADI.
Aadi Bioscience, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AADI stock is 2.63% volatile and has beta coefficient of 0.19. Check out the list of the most volatile stocks — is Aadi Bioscience, Inc. there?
AADI earnings for the last quarter are −0.60 USD per share, whereas the estimation was −0.72 USD resulting in a 17.13% surprise. The estimated earnings for the next quarter are −0.65 USD per share. See more details about Aadi Bioscience, Inc. earnings.
Aadi Bioscience, Inc. revenue for the last quarter amounts to ‪5.96 M‬ USD despite the estimated figure of ‪6.62 M‬ USD. In the next quarter revenue is expected to reach ‪6.29 M‬ USD.
Yes, you can track Aadi Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
AADI stock has risen by 3.19% compared to the previous week, the month change is a 9.35% fall, over the last year Aadi Bioscience, Inc. has showed a 75.63% decrease.
AADI net income for the last quarter is ‪−16.27 M‬ USD, while the quarter before that showed ‪−16.30 M‬ USD of net income which accounts for 0.20% change. Track more Aadi Bioscience, Inc. financial stats to get the full picture.
Today Aadi Bioscience, Inc. has the market capitalization of ‪46.65 M‬, it has decreased by 7.83% over the last week.
No, AADI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AADI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aadi Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AADI reached its all-time high on Sep 18, 2017 with the price of 101.25 USD, and its all-time low was 1.55 USD and was reached on Jan 17, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 89.00 employees. See our rating of the largest employees — is Aadi Bioscience, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aadi Bioscience, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aadi Bioscience, Inc. stock shows the sell signal. See more of Aadi Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Aadi Bioscience, Inc. future price: according to them, AADI price has a max estimate of 16.00 USD and a min estimate of 5.00 USD. Read a more detailed Aadi Bioscience, Inc. forecast: see what analysts think of Aadi Bioscience, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aadi Bioscience, Inc. EBITDA is ‪−71.76 M‬ USD, and current EBITDA margin is −294.67%. See more stats in Aadi Bioscience, Inc. financial statements.